Contact details:+61 (0) 8 8128 4443
Qualifications:PhD, BSc (Honours)
Dr Lisa Yelland. is a NHMRC Postdoctoral Research Fellow in the Healthy Mothers, Babies and Children Theme at the South Australian Health and Medical Research Institute and in the School of Public Health at the University of Adelaide. As a biostatistician specializing in maternal and infant health, her research broadly aims to improve the statistical quality of perinatal trials. She is currently investigating methods for designing and analysing such trials when clustering is present due to the inclusion of multiple births.
In her current role she leads research projects on statistical methodology for randomised trials and contributes statistical expertise as a member of multidisciplinary research teams. Her previous roles include Senior Statistician and Director of Data Management at the Australian Research Centre for Health of Women and Babies (2011-2013), and Statistician then Senior Statistician at the Data Management and Analysis Centre (2004-2013), both at the University of Adelaide. She completed her PhD on statistical methods for analysing randomised trials in 2011.
2015 - Best publication by an early career researcher for the paper 'Applying the intention-to-treat principle in practice: Guidance on handling randomisation errors' by Yelland et al., School of Public Health, the University of Adelaide.
2012 - Doctoral Research Medal for outstanding research, the University of Adelaide.
2011 - Best thesis award, School of Population Health and Clinical Practice.
2010 - Best presentation award, School of Population Health and Clinical Practice HDR Research Symposium.
2009 - Sir Richard Stawell Memorial Prize, awarded for an article on a medical subject of clinical significance published in the Medical Journal of Australia for the paper 'Does point-of-care testing lead to the same or better adherence to medication: Results from the PoCT in General Practice Trial' by Gialamas et al.
2009 - Wyeth/MJA Award, awarded for the best research article published in the Medical Journal of Australia for the paper 'Effectiveness of point-of-care testing for therapeutic control of chronic conditions: results from the PoCT in General Practice Trial' by Bubner et al.
2009 - Runner up prize, best presentation by a young statistician, International Biometric Society Australasian Region Conference in New Zealand.
2008 - Awarded Highly Commended in the Best Technical Article category at the National Institute of Forensic Science Best Paper Awards for the paper 'Inter and intra-subject variability of ethanol pharmacokinetic parameters: Comparing long and short time periods and different doses' by Yelland et al.
2014 - Robinson Research Institute travel grant to attend the LIMIT/UPBEAT International Collaboration Alliance Workshop, France.
2008 - 2011 - Australian Postgraduate Award PhD scholarship.
2008 – 2011 - Discipline of Public Health PhD top-up scholarship.
2009 - CSIRO scholarship to attend the International Biometric Society Australasian Region Conference New Zealand.
Sullivan T, Yelland L, Lee K, Ryan P, Salter A. Treatment of missing data in follow-up studies of randomised controlled trials: a systematic review of the literature. Clin Trials, in press.
Yelland L, Sullivan T, Price D, Lee K. Sample size calculations for randomised trials including both independent and paired data. Stat Med, 2017; 36:1227-39.
Gould J, Treyvaud K, Yelland L, Anderson P, Smithers L, McPhee A, Makrides M. Seven-year follow-up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA, 2017; 317:1173-75.
Lei Y, Carlson S, Yelland L, Makrides M, Gibson R, Gajewski B. Comparison of dichotomized and distributional approaches in rare event clinical trial design: a fixed Bayesian design. J Appl Stat, 2017; 44:1466-78.
Gould J, Anderson A, Yelland L, Smithers L, Skeaff M, Zhou S, Gibson R, Makrides M. Association of cord blood vitamin D with early childhood growth and neurodevelopment. J Paediatr Child Health, 2017; 53:75-83.
Moran L, Fraser L, Sundernathan T, Deussen A, Louise J, Yelland L, Grivell R, Macpherson A, Gillman M, Robinson J, Owens J, Dodd J. The effect of an antenatal lifestyle intervention in overweight and obese women on circulating cardiometabolic and inflammatory biomarkers: secondary analyses from the LIMIT randomised trial. BMC Med, 2017; 15:32.
Yelland L, Makrides M, McPhee A, Quinlivan J, Gibson R. Importance of adequate sample sizes in fatty acid intervention trials. Prostag Leukotr Ess, 2016; 107:8-11.
Yelland L, Gajewski B, Colombo J, Gibson R, Makrides M, Carlson S. Predicting the effect of maternal docosahexaenoic acid (DHA) supplementation to reduce early preterm birth in Australia and the United States using results of within country randomized controlled trials. Prostag Leukotr Ess, 2016; 112:44-49.
Yelland L, Sullivan T, Voysey M, Lee K, Cook J, Forbes A. Applying the intention to treat principle in practice: guidance on handling randomisation errors. Clinical Trials 2015;12:418-23.
Yelland L, Sullivan T, Pavlou M, Seaman S. Analysis of randomised trials including multiple births when birth size is informative. Paediatr Perinat Epidemiol, 2015; 29:567-75.
Yelland L, Sullivan T, Makrides M. Accounting for multiple births in randomised trials: a systematic review. Arch Dis Child, 2015; 100:F116-20.
Makrides M, Gould J, Gawlik N, Yelland L, Smithers L, Anderson P, Gibson R. Four Year Follow-up of Children Born to Women in a Randomized Controlled Trial of DHA Supplementation during Pregnancy JAMA 2014; 311:1802-04.
Dodd J, Turnbull D, McPhee A, Deussen A, Grivell R, Yelland L, Crowther C, Wittert G, Owens J, Robinson J. Antenatal lifestyle advice for women who are overweight or obese: the LIMIT randomised trial. BMJ 2014; 348:g1285.
Dodd J, McPhee A, Turnbull D, Yelland L, Deussen A, Grivell R, Crowther C, Wittert G, Owens J, Robinson J. The effects of antenatal dietary and lifestyle advice for women who are overweight or obese on neonatal health outcomes: the LIMIT randomised trial. BMC Med, 2014; 12:163.
Zhou S, Yelland L, McPhee A, Quinlivan J, Gibson R, Makrides M. Fish-oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. Am J Clin Nutr 2012; 95:1378-84.
Yelland L, Salter A, Ryan P. Performance of the modified Poisson regression approach for estimating relative risks from clustered prospective data. Am J Epidemiol, 2011; 174(8):984-92.
Makrides M, Gibson R, McPhee A, Yelland L, Quinlivan J, Ryan P. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. J Am Med Assoc, 2010; 304(15):1675-83.